in June that Cerebral had put hundreds of patients at risk, based on more than 2,000 incident reports by employees flagging concerns about patient care. then-CEO Kyle Robertson and handed the reins to Mou, who previously served as Cerebral's chief medical officer.
In a statement to Insider in December, a spokesperson for Cerebral said that the company is not fighting for its survival, and that the company is using technology to advance behavioral health, including by measuring clinical outcomes with surveys. Cerebral's pharmacy of choice, Truepill, has also been affected by Cerebral's troubles. The DEA said in December that
Truepill's ability to fill controlled substances, citing allegations that the online pharmacy startup unlawfully dispensed controlled substances for online mental-health startups like Cerebral.